Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Nausea × Cyclophosphamide × Clear all

Phase

Status

Sponsor Class

OTHER 6 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 61 Lymphoma, Large B-Cell, Diffuse 46 Neoplasms 39 Multiple Myeloma 38 Lymphoma, Non-Hodgkin 37 Lymphoma 34 Recurrence 29 Carcinoma, Non-Small-Cell Lung 29 Lymphoma, Follicular 28 Leukemia, Lymphocytic, Chronic, B-Cell 26 Lymphoma, B-Cell 23 Leukemia, Myeloid, Acute 21 Triple Negative Breast Neoplasms 17 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Lymphoma, Mantle-Cell 16 Leukemia 15 Pancreatic Neoplasms 12 Ovarian Neoplasms 12 Colorectal Neoplasms 11 Neoplasm Metastasis 10 Melanoma 10 Lymphoma, B-Cell, Marginal Zone 10 Stomach Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 8 Prostatic Neoplasms 8 Lymphoma, T-Cell, Peripheral 8 Liposarcoma, Myxoid 8 Carcinoma, Renal Cell 8 Neutropenia 7 Myelodysplastic Syndromes 7

Interventions

casopitant 6 Ondansetron 6 Dexamethasone 6 Aprepitant 5 Palonosetron 3 Granisetron 3 Duration of Therapy 2 dolasetron 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 alizapride 1 Tropisetron 1 Tablets 1 Metoclopramide 1 Injections, Intravenous 1 Exercise 1 Docetaxel 1 Cyclophosphamide 1 Calcium Dobesilate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00334646 2017-11-17

Cyclophosphamide Drug Interaction Study In Cancer Patients

GlaxoSmithKline

Phase 1 Terminated

Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡